Aspirin inhibits platelet function by irreversibly inhibiting the synthesis of thromboxane A2
(TxA2). Aspirin, at low doses, is widely used for cardiovascular prevention. Gastrointestinal …

Aspirin is a very useful medication for the prevention of cardiovascular thrombotic events in
patients with or those at risk for cardiovascular disease (CVD). Aspirin, however, carries an …

ContextMore than 50 million US adults take aspirin regularly for long-term prevention of
cardiovascular disease, typically either 81 mg/d or 325 mg/d. Controversy remains regarding …

This article describes the mechanism of action, pharmacokinetics, and pharmacodynamics
of aspirin at doses used for cardiovascular prevention and provides specific management …

Aspirin has been the cornerstone of therapy for the secondary prevention treatment of
patients with cardiovascular disease since landmark trials were completed in the late 1970s …

Abstract Purpose of Review In this review article, a detailed analysis of the current literature
is provided, along with a “glimpse” into what the future holds for aspirin in the context of …

Cardiovascular disease, which includes coronary heart disease, cerebrovascular disease
and peripheral artery disease, is the leading cause of death in developed countries …

Aims: To review the current knowledge of the benefits and risks of long‐term aspirin therapy
for the prevention of cardiovascular disease. Methods: Relevant articles published in …

Low-dose aspirin represents the best option in the secondary prevention of coronary artery
disease, but its extensive use in primary prevention is limited by the occurrence of gastric …

Background and Aims: Aspirin leads to substantial benefits for the secondary prevention of
cardiovascular disease (CVD). We aimed to cast more light on aspirin's role for the primary …